Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Emphasys Medical
company
About
Emphasys Medical develops therapeutic devices for the treatment of patients with emphysema and other breathing disorders.
- 11 - 50
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $18.70M
- Industries
- Biotechnology,Developer Platform,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Emphasys Medical develops therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal.Emphasys Medical was founded in 2000 and is based in Redwood City, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$18.70M
Emphasys Medical has raised a total of
$18.70M
in funding over 2 rounds. Their latest funding was raised on
Jul 27, 2006 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 27, 2006 | Series E | $18.70M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Emphasys Medical is funded by 1 investors.
Trellis Health Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
